Back
Long-term observation reveals high-frequency engraftment of human acute myeloid leukemia in immunodeficient mice.
Journal article

Long-term observation reveals high-frequency engraftment of human acute myeloid leukemia in immunodeficient mice.

  • Paczulla AM University of Basel and University Hospital Basel, Department of Biomedicine, Switzerland.
  • Dirnhofer S University of Basel and University Hospital Basel, Department of Pathology, Switzerland.
  • Konantz M University of Basel and University Hospital Basel, Department of Biomedicine, Switzerland.
  • Medinger M University of Basel and University Hospital Basel, Clinic for Hematology, Switzerland.
  • Salih HR Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner site Tübingen, Department for Internal Medicine II, Tübingen, Germany.
  • Rothfelder K Clinical Collaboration Unit Translational Immunology, German Cancer Consortium (DKTK) and German Cancer Research Center (DKFZ), Partner site Tübingen, Department for Internal Medicine II, Tübingen, Germany.
  • Tsakiris DA University of Basel and University Hospital Basel, Diagnostic Hematology, Switzerland.
  • Passweg JR University of Basel and University Hospital Basel, Clinic for Hematology, Switzerland.
  • Lundberg P University of Basel and University Hospital Basel, Diagnostic Hematology, Switzerland.
  • Lengerke C University of Basel and University Hospital Basel, Department of Biomedicine, Switzerland claudia.lengerke@unibas.ch.
Show more…
  • 2017-02-11
Published in:
  • Haematologica. - 2017
Acute Disease
Animals
Antigens, CD34
Disease Models, Animal
Gene Expression Profiling
Gene Expression Regulation, Leukemic
Graft Survival
Humans
Kaplan-Meier Estimate
Leukemia, Myeloid
Mice, Inbred NOD
Mice, Knockout
Mice, SCID
Neoplasm Transplantation
Time Factors
Transplantation, Heterologous
English Repopulation of immunodeficient mice remains the primary method for functional assessment of human acute myeloid leukemia. Published data report engraftment in ~40-66% of cases, mostly of intermediate- or poor-risk subtypes. Here we report that extending follow-up beyond the standard analysis endpoints of 10 to 16 weeks after transplantation permitted leukemic engraftment from nearly every case of xenotransplanted acute myeloid leukemia (18/19, ~95%). Xenogeneic leukemic cells showed conserved immune pheno-types and genetic signatures when compared to corresponding pre-transplant cells and, furthermore, were able to induce leukemia in re-transplantation assays. Importantly, bone marrow biopsies taken at standardized time points failed to detect leukemic cells in 11/18 of cases that later showed robust engraftment (61%, termed "long-latency engrafters"), indicating that leukemic cells can persist over months at undetectable levels without losing disease-initiating properties. Cells from favorable-risk leukemia subtypes required longer to become detectable in NOD/SCID/IL2Rγnull mice (27.5±9.4 weeks) than did cells from intermediate-risk (21.9±9.4 weeks, P<0.01) or adverse-risk (17±7.6 weeks; P<0.0001) subtypes, explaining why the engraftment of the first was missed with previous protocols. Mechanistically, leukemic cells engrafting after a prolonged latency showed inferior homing to the bone marrow. Finally, we applied our model to favorable-risk acute myeloid leukemia with inv(16); here, we showed that CD34+ (but not CD34-) blasts induced robust, long-latency engraftment and expressed enhanced levels of stem cell genes. In conclusion, we provide a model that allows in vivo mouse studies with a wide range of molecular subtypes of acute myeloid leukemia subtypes which were previously considered not able to engraft, thus enabling novel insights into leukemogenesis.
Language
  • English
Open access status
gold
Identifiers
Persistent URL
https://sonar.ch/global/documents/73080
Statistics
Document views: 19 File downloads: